The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 13, 2015
Filed:
Jul. 31, 2009
Applicants:
Colin Palmer, Dundee, GB;
John Foerster, Dundee, GB;
Nainamalai Sitherswaran, Dundee, GB;
Inventors:
Assignee:
University Court of the University of Dundee, Dundee, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01K 67/00 (2006.01); A01K 67/027 (2006.01); C07K 14/47 (2006.01); C12N 15/85 (2006.01);
U.S. Cl.
CPC ...
A01K 67/0275 (2013.01); C07K 14/4702 (2013.01); C12N 15/8509 (2013.01); A01K 2207/15 (2013.01); A01K 2207/20 (2013.01); A01K 2217/00 (2013.01); A01K 2217/052 (2013.01); A01K 2217/203 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0368 (2013.01); C12N 2830/008 (2013.01); C12N 2840/002 (2013.01);
Abstract
Non-human animals which overexpress PPARd or which express transgenic PPARd are useful as models for inflammatory skin conditions such as psoriasis. Test substances can be screened to assess their suitability for the treatment of inflammatory skin conditions such as psoriasis. Methyl 3-({[2-(methoxy)-4-phenyl]amino}sulfonyl)-2-thiophenecarboxylate can be administered topically for the prevention or treatment of psoriasis.